In addition, the induction of SREBP-1-driven de novo synthesis of endogenous lipids has become increasingly apparent in many drug-resistant cancer cells [39], and sustained lipogenesis has been shown to be a key mediator of acquired resistance toward molecularly directed drugs in oncogene-driven melanoma [32] and NSCLC [33, 78]. Here, SREBF1 is linked to melanoma.